Who
Jane Buchan
Director
Company insider
Files Form 4 as: Director, Immix Biopharma; Director, Globe Life.
In numbers
- Trades disclosed
- 71
- Buys
- 2
- Sells
- 12
- Bought
- $287K
- Sold
- $4.1M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 3 Jan 2006
- Last trade
- 22 May 2026
- Last filed
- 29 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 May 2026filed 29 May 2026 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 22 May 2026filed 29 May 2026 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 22 May 2026filed 29 May 2026 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 22 May 2026filed 29 May 2026 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 20 Jun 2025filed 23 Jun 2025 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,000 at $0.00 | filing |
| 11 Jun 2024filed 21 Jun 2024 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,000 at $0.00 | filing |
| 20 May 2024filed 20 May 2024 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Code A | —1,127 | filing |
| 15 May 2024filed 20 May 2024 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,436 at $0.00 | filing |
| 15 May 2024filed 20 May 2024 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,153 at $0.00 | filing |
| 15 May 2024filed 20 May 2024 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Code A | —1,332 at $0.00 | filing |
| 2 Jan 2024filed 3 Jan 2024 | GL Globe Lifeoption or derivative · Insurance | SEC FORM 4 Code A | —1,728 at $0.00 | filing |
| 12 Dec 2023filed 13 Dec 2023 | GL Globe LifeInsurance | SEC FORM 4 Sold | $125K1,000 at $124.50 | filing |
| 21 Nov 2023filed 22 Nov 2023 | GL Globe LifeInsurance | SEC FORM 4 Code G | —10 at $0.00 | filing |
| 16 Nov 2023filed 17 Nov 2023 | GL Globe LifeInsurance | SEC FORM 4 Code G | —425 at $0.00 | filing |
| 7 Sep 2023filed 11 Sep 2023 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $49K20,000 at $2.46 | filing |
| 11 Aug 2023filed 14 Aug 2023 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 30 Jun 2023filed 30 Jun 2023 | GL Globe LifeInsurance | SEC FORM 4 Code G | —235 at $0.00 | filing |
| 16 Mar 2023filed 16 Mar 2023 | GL Globe LifeInsurance | SEC FORM 4 Sold | $201K1,900 at $105.95 | filing |
| 3 Jan 2023filed 9 Jan 2023 | GL Globe LifeInsurance | SEC FORM 4 Code A | —1,422 at $0.00 | filing |
| 29 Nov 2022filed 29 Nov 2022 | GL Globe LifeInsurance | SEC FORM 4 Code G | —430 at $0.00 | filing |
News
Globe Life (NYSE:GL) Price Target Raised to $191.00GL · themarketsdaily.com · 15 Oct 2026
0 headlines in the last 90 days name Jane Buchan; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.